Enfermedad de Alzheimer y degeneración macular asociada a la edad

  1. H.M. Roca-Santiago
  2. J.R. Lago-Bouza
  3. J.C. Millán-Calenti
  4. F. Gómez-Ulla-Irazazábal
Journal:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Year of publication: 2006

Volume: 81

Issue: 2

Pages: 73-78

Type: Article

DOI: 10.4321/S0365-66912006000200006 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Archivos de la Sociedad Española de Oftalmologia

Abstract

Objectives: We analysed different risk factors involved in the onset of both Alzheimer’s disease (AD) and age-related macular degeneration (ARMD). The putative relation between both disorders was studied. Methods: We studied 57 subjects to determine the correlation between AD and ARMD. Thirty-three of the subjects suffered dementia (cases), whereas 24 of them (controls) did not. Firstly, anamnesis was performed for all individuals. We then examined the macular area of the eye using a non-midriatic TRV-50VT fundus camera. Significant odds ratio (OR) results were used as a statistical tool to survey the putative link between AD and ARMD. Results: The OR test results showed that ARMD was associated with Alzheimer’s disease. The occurrence of ARMD was significantly higher for cases (42.4%) than for controls (25%). On this basis, we inferred a cause-effect relation linking both variables. Our dataset suggested that the control group was more protected against ARMD than the case group, as revealed by Fisher’s exact test (P = 0.649). However, such a difference between both groups was not strongly supported. Conclusions: We suggest that AD and ARMD may have common factors concerning etiology and pathogenesis. Our dataset did not allow us to show a significant relation between both disorders, which is likely due to sample size and/or to age differences in the two studied groups. Even so, we feel that the possibility of such an association is justified, and future surveys to test this possibility are warranted.

Bibliographic References

  • Klein, R, Klein, BE, Linton, KL. (1992). Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. 99. 933-943
  • Klein, R, Klein, BE, Jensen, SC, Meuer, SM. (1997). The five-year incidence and progression of age-related maculopathy. Ophthalmology. 104. 7-21
  • Dentchev, T, Milam, AH, Lee, VM, Trojanowski, JQ, Dunaief, JL. (2003). Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis. 9. 184-190
  • Vingerling, JR, Dielemans, I, Hofman, A, Grobbee, DE, Hijmering, M, Kramer, CF. (1995). The Prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 102. 205-210
  • Morris, JC, Storandt, M, McKeel, DW Jr, Rubin, EH, Price, JL, Grant, EA. (1996). Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 46. 707-719
  • Anderson, DH, Ozaki, S, Nealon, M, Neitz, J, Mullins, RF, Hageman, GS. (2001). Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol. 131. 767-781
  • Corder, EH, Saunders, AM, Strittmatter, WJ, Schmechel, DE, Gaskell, PC, Small, GW. (1993). Gene dose of apolipoprotein e type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261. 921-923
  • Tang, MX, Stern, Y, Marder, K, Bell, K, Gurland, B, Lantigua, R. (1998). The APOE epsilon 4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 279. 751-755
  • Saunders, AM, Strittmatter, WJ, Schmechel, D, St George-Hyslop, PH, Pericak-Vance, MA, Joo, SH. (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer´s disease. Neurology. 43. 1467-1472
  • McKhann, G, Drachman, D, Folstein, M, Katzman, R, Price, D, Stadlan, EM. (1984). Clinical diagnosis of Alzheimer´s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer´s Disease. Neurology. 34. 939-944
  • (2002). Manual diagnóstico y estadístico de los trastornos mentales: Versión española de la 4th edición, Texto Revisado (DSM-IV-TR).. Masson SA. Barcelona.
  • Bird, AC, Bressler, NM, Bressler, SB, Chisholm, IH, Coscas, G, Davis, MD. (1995). An international classification and grading system for age-related maculopathy and age-related macular degeneration: The International ARM Epidemiological Study Group. Surv Ophthalmol. 39. 367-374
  • Seddon, JM, Willett, WC, Speizer, FE, Hankinson, SE. (1996). A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA. 276. 1141-1146
  • Klein, R, Klein, BE, Moss, SE. (1998). Relation of smoking to the incidence of age-related maculopathy: The Beaver Dam Eye Study. Am J Epidemiol. 147. 103-110
  • Ott, A, Slooter, AJ, Hofman, A, van Harskamp, F, Witteman, JC, Van Broeckhoven, C. (1998). Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet. 351. 1840-1843
  • Klaver, CC, Ott, A, Hofman, A, Assink, JJ, Breteler, MM, de Jong, PT. (1999). Is age-related maculopathy associated with Alzheimer's disease?: The Rotterdam Study. Am J Epidemiol. 150. 963-968
  • Blanks, JC, Torigoe, Y, Hinton, DR, Blanks, RH. (1991). Retinal degeneration in the macula of patients with Alzheimer's disease. Ann N Y Acad Sci. 640. 44-46
  • Johnson, LV, Leitner, WP, Rivest, AJ, Staples, MK, Radeke, MJ, Anderson, DH. (2002). The Alzheimer's: A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA. 99. 11830-11835
  • Anderson, DH, Mullins, RF, Hageman, GS, Johnson, LV. (2002). A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 134. 411-431
  • Hofman, A, Ott, A, Breteler, MM, Bots, ML, Slooter, AJ, van Harskamp, F. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 349. 151-154
  • Hyman, L, Schatat, AP, He, Q, Leske, MC. (2000). Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol. 118. 351-358
  • Hirvela, H, Luukinen, H, Laara, E, Sc, L, Laatikainen, L. (1996). Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology. 103. 871-878
  • Vingerling, JR, Dielemans, I, Bots, ML, Hofman, A, Grobbee, DE, Jong, PTV. (1995). Age-related macular degeneration is associated with atherosclerosis: The Rotterdam Study. Am J Epidemiol. 142. 404-409
  • Pauleikhoff, D, Chen, JC, Chisholm, IH, Bird, AC. (1990). Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol. 109. 211-217
  • Ellis, RJ, Olichney, JM, Thal, LJ, Mirra, SS, Morris, JC, Beekly, D. (1996). Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology. 46. 1592-1596
  • Souied, EH, Benlian, P, Amouyel, P, Feingold, J, Lagarde, JP, Munnich, A. (1998). The epsilon 4 allele of the apolipoprotein e gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol. 125. 353-359
  • Ott, A, Breteler, MM, van Harskamp, F, Stijnen, T, Hofman, A. (1998). Incidence and risk of dementia: The Rotterdam Study. Am J Epidemiol. 147. 574-580
  • Strittmatter, WJ, Saunders, AM, Schmechel, D, Pericak-Vance, M, Enghild, J, Salvesen, GS. (1993). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 90. 1977-1981
  • Tsai, MS, Tangalos, EG, Petersen, RC, Smith, GE, Schaid, DJ, Kokmen, E. (1994). Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet. 54. 643-649
  • Blanks, JC, Hinton, DR, Sadun, AA, Miller, CA. (1989). Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res. 501. 364-372
  • Penfold, PL, Madigan, MC, Gillies, MC, Provis, JM. (2001). Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 20. 385-414
  • Mullins, RF, Russell, SR, Anderson, DH, Hageman, GS. (2000). Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J.. 14. 835-846
  • Klaver, CC, Kliffen, M, van Duijn, V, Hofman, A, Cruts, M, Grobbee, DE. (1998). Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet. 63. 200-206
  • Davignon, J, Cohn, JS, Mabile, L, Bernier, L. (1999). Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta. 286. 115-143
Data source: Dialnet